Squarepoint Ops LLC - PRELUDE THERAPEUTICS INC ownership

PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 52 filers reported holding PRELUDE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Squarepoint Ops LLC ownership history of PRELUDE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$274,398
+218.8%
88,802
+364.3%
0.00%
Q2 2023$86,072
-15.6%
19,127
-2.5%
0.00%
-100.0%
Q2 2022$102,000
-52.8%
19,618
-37.4%
0.00%0.0%
Q1 2022$216,000
-64.4%
31,334
-35.6%
0.00%
-50.0%
Q4 2021$606,000
-59.1%
48,667
+134.8%
0.00%
-81.8%
Q4 2020$1,483,000
-9.0%
20,726
-61.7%
0.01%
-50.0%
Q3 2020$1,629,00054,0660.02%
Other shareholders
PRELUDE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Orbimed Advisors 10,039,691$69,274,0001.12%
Baker Brothers Advisors 10,123,824$69,854,0000.40%
HHLR ADVISORS, LTD. 583,333$4,025,0000.08%
Rock Springs Capital Management LP 368,959$2,546,0000.06%
PDT Partners, LLC 71,822$496,0000.04%
Virtus ETF Advisers LLC 13,048$90,0000.04%
Corton Capital Inc. 10,918$75,0000.03%
GSA CAPITAL PARTNERS LLP 23,201$160,0000.02%
OCCUDO QUANTITATIVE STRATEGIES LP 24,238$167,0000.01%
IndexIQ Advisors LLC 56,750$392,0000.01%
View complete list of PRELUDE THERAPEUTICS INC shareholders